Corrigendum to “DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers” (Pathology - Research and Practice (2018) 214(12) (2075–2080), (S0344033818309245), (10.1016/j.prp.2018.10.005))
Son, H.
pathology research and practice2020Vol. 216pp. 0-0